A study shows that transformer-based chemical language models can transform molecular cores and substituents into novel and diverse compounds. The generated molecules exhibit good synthetic accessibility and potential biological relevance, with significant implications for drug design.

With revenues nearing €5 billion and more than 30 million consumers, Italy leads the European market for dietary supplements. Underpinning this leadership are the central role of pharmacies, a cultural perception of prevention, and the industry’s capacity for innovation. For the pharma supply chain, this opens up challenges of governance, regulation, and competitive positioning.

Genenta announces Long-Term follow-up observations in brain tumor (GBM) study with emerging survival signals

BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices

In the March multimedia magazine, we explore the impact of artificial intelligence and cybersecurity regulations in the pharmaceutical industry. As artificial intelligence reshapes drug development,...

This special issue explores the impact of automation and AI on pharmaceutical production—across GxP, sustainability, and digitalization.